Assessing ‘no evidence of disease activity’ status in patients with relapsing–remitting multiple sclerosis: a long-term follow-up

Assessing ‘no evidence of disease activity’ status in patients with relapsing–remitting multiple sclerosis: a long-term follow-up

IntroductionMultiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS with an autoimmune pathogenesis. Over the years, numerous disease-modifying therapies (DMTs) have proven effective in disease control; to date, there is a need to identify a personalized treatment effectiv...

Full description

Bibliographic Details
Main Authors: Chiara Zilli, Pietro Scribani Rossi, Arianna Di Stadio, Mariangela Fratino, Giada Giuliani, Rosanna Annecca, Gaetano Russo, Vittorio Di Piero, Marta Altieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Neurology
Subjects:
NEDA
multiple sclerosis
DMT
relapse
EDSS
second-line treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1187851/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1187851/full

Similar Items